Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology
Disease Category: Mantle Cell Lymphoma
Location: United States, ND

Clinical Trial Details

Overview

Research Study Summary

Newly Diagnosed Mantle Cell Lymphoma who are not eligible for a bone marrow transplant.

Purpose

Newly Diagnosed Mantle Cell Lymphoma who are not eligible for a bone marrow transplant.

Patient Inclusion Criteria:

  • 18 + years of age,
  • diagnosis of MCL, at least 1 measurable site of disease, not eligible or not considered for bone marrow transplantation

Patient Exclusion Criteria:

  • Prior treatment with VELCADE, major surgery with 2 weeks before randomization, peripheral neuropathy or neuropathic pain, diagnosed or treated for a malignancy other than MCL within 1 year of randomization

To Learn more
Phase

3

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Dr. Tom Davis, Director of Business Development
Legacy Pharma Research
601 N. 5th St.
Bismarck, ND 58501
Phone: 701-751-1128
Fax: 701-751-1131

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 163100

Date Last Changed: July 24, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.